Skip to main content
. 2014 Jun 11;11(9):863–869. doi: 10.7150/ijms.8912

Table 4.

Predictors for Major Adverse Events after VATS lobectomy

Univariate Multivariate
Variable N P Value OR (95%CI) P Value
Age, y <0.001 2.919 (1.932-4.409) <0.001
≥70 48
<70 86
Gender 0.014 1.183 (0.741-1.888) 0.482
Male 90
Female 44
Pack year of Smoking 0.002 1.399 (0.900-2.713) 0.136
≥20 54
<20 80
BMI (kg/m2) 0.062 1.408 (0.822-2.413) 0.213
>28 18
18-28 105
<18 11
Location of Tumor 0.326
Left Upper Lobe 25
Left Lower Lobe 26
Right Upper Lobe 42
Right Middle Lobe 14
Right Lower Lobe 27
Comorbidities <0.001 1.764 (1.164-2.673) 0.007
Yes 49
No 85
FEV1% 0.001 1.899 (0.841-4.290) 0.123
≥50 124
<50 10
TNM stage 0.006 1.085 (0.934-1.262) 0.286
IA 32
IB 65
IIA 7
IIB 2
IIIA 28
Tumor size (cm) 0.038 1.395 (0.890-2.186) 0.147
≥3 92
<3 42
Nodal status 0.252
N0 101
N1 9
N2 24
Histology 0.089 0.952(0.739-1.227) 0.705
Adenocarcinoma 84
Squamous carcinoma 31
Others 19
Type of VATS 0.023 2.868 (1.278-6.437) 0.011
Complete 126
Hybrid 8
Number of ports 0.209
3
4
Operative time (min) <0.001 2.440 (1.467-4.057) 0.001
≥240 27
<240 107
Blood loss (ml) 0.072 0.987 (0.588-1.654) 0.959
≥600 25
<600 109